Login / Signup

High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure.

Myoung Kyu LeeJaehwa ChoiBonil ParkBumjoon KimSeok Jeong LeeSang-Ha KimSuk Joong YongEun Hee ChoiWon-Yeon Lee
Published in: The clinical respiratory journal (2018)
There was no difference of the 30-day mortality and intubation rate between HFNC and NIV groups.
Keyphrases